Walvax Biotechnology Co (SZSE:300142) FCF Margin % : -38.21% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Walvax Biotechnology Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-229 Mil. Walvax Biotechnology Co's Revenue for the three months ended in Mar. 2024 was ¥600 Mil. Therefore, Walvax Biotechnology Co's FCF Margin % for the quarter that ended in Mar. 2024 was -38.21%.

As of today, Walvax Biotechnology Co's current FCF Yield % is 0.03%.

The historical rank and industry rank for Walvax Biotechnology Co's FCF Margin % or its related term are showing as below:

SZSE:300142' s FCF Margin % Range Over the Past 10 Years
Min: -57.56 Med: -29.54 Max: 4.58
Current: 0.14

During the past 13 years, the highest FCF Margin % of Walvax Biotechnology Co was 4.58%. The lowest was -57.56%. And the median was -29.54%.

SZSE:300142's FCF Margin % is ranked better than
50.24% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 0.08 vs SZSE:300142: 0.14

Walvax Biotechnology Co FCF Margin % Historical Data

The historical data trend for Walvax Biotechnology Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co FCF Margin % Chart

Walvax Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-25.85

-9.97

-11.50

2.17

4.58

Walvax Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-5.56	-2.42	22.02	5.10	-38.21

Competitive Comparison of Walvax Biotechnology Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Walvax Biotechnology Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Walvax Biotechnology Co's FCF Margin % falls into.

Walvax Biotechnology Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Walvax Biotechnology Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	188.253	/	4113.772
	=	4.58 %

Walvax Biotechnology Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-229.142	/	599.754
	=	-38.21 %

Walvax Biotechnology Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Walvax Biotechnology Co (SZSE:300142) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Keyuan Road No. 99, 19th Floor, Building 9A, Dingyi Tiancheng Residential Quarter, High & New Tech Development Zone, Yunnan Province, Kunming, CHN, 650106

Website

http://www.walvax.com

Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.

Executives

Wu Yun Yan	Executives
Zhao Jin Long	Executives
Yao Wei	Executives
Zhou Hua	Executives
Shi Jing	Executives
Jiang Run Sheng	Directors, executives
Gong Sun Qing	Executives
	Executives
Yuan Lin	Executives
Fang Guo Liang	Executives
Li Yun Chun	Director
Huang Zhen	Director
Zhang Li	Secretary Dong
Yang Hong Wei	Supervisors
Xu Ke Ren	Executives

Walvax Biotechnology Co (SZSE:300142) Headlines

No Headlines